postoperative abnormal behaviors such as agitation or restless in children undergoing general anesthesia
Conditions
Interventions
None listed
Sponsors
Department of Anesthesiology and Critical Care Medicine, Yokohama City University Graduate School of Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: All randomized controlled trials comparing droperidol with any comparator (i.e., placebo, any drugs, or no treatment) administered during or before general anesthesia in children are included in this study. Eligibility is not restricted by language, type of surgery, or anesthetic technique.
Exclusion criteria
Exclusion criteria: We exclude studies which did not report our primary or secondary outcomes (i.e., postoperative abnormal behaviors such as agitation or restless, extrapyramidal symptoms, or sedation). We exclude studies which did not compare droperidol with any comparator (e.g., droperidol and midazolam vs. fentanyl), whereas we include studies "droperidol and drug A vs. drug A" because we can count the study as "droperidol vs. placebo". We also exclude data from abstracts, posters, case reports, comments or letters to the editor, reviews, and animal studies.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcomes of this present meta-analysis are the incidence of postoperative abnormal behaviors such as agitation, restless, or extrapyramidal symptoms. | — |
Secondary
| Measure | Time frame |
|---|---|
| The secondary outcomes are the incidence of sedation. | — |
Countries
Japan
Contacts
Public ContactTakahiro Mihara
Yokohama City University Graduate School of Medicine Department of Anesthesiology and Critical Care Medicine
Outcome results
None listed